BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 24877581)

  • 1. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
    Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
    Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
    Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
    Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
    Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
    Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
    J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT.
    Wu HB; Wang L; Wang QS; Han YJ; Li HS; Zhou WL; Tian Y
    Biomed Res Int; 2015; 2015():243681. PubMed ID: 25879020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
    Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
    Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
    World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.